163 related articles for article (PubMed ID: 15088316)
21. Drug-induced cutaneous lupus erythematosus: 88 new cases.
Laurinaviciene R; Sandholdt LH; Bygum A
Eur J Dermatol; 2017 Feb; 27(1):28-33. PubMed ID: 27799135
[TBL] [Abstract][Full Text] [Related]
22. Drug-induced subacute cutaneous lupus erythematosus associated with docetaxel chemotherapy: a case report.
Wong NY; Parsons LM; Trotter MJ; Tsang RY
BMC Res Notes; 2014 Nov; 7():785. PubMed ID: 25369825
[TBL] [Abstract][Full Text] [Related]
23. Case report: verapamil-induced subacute cutaneous lupus erythematosus.
Kurtis B; Larson MJ; Hoang MP; Cohen JB
J Drugs Dermatol; 2005; 4(4):506-8. PubMed ID: 16004027
[TBL] [Abstract][Full Text] [Related]
24. Thiazide diuretics induce cutaneous lupus-like adverse reaction.
Brown CW; Deng JS
J Toxicol Clin Toxicol; 1995; 33(6):729-33. PubMed ID: 8523503
[TBL] [Abstract][Full Text] [Related]
25. Rowell's Syndrome Triggered by Omeprazole.
Pozharashka J; Dourmishev L; Balabanova M; Vassileva S; Miteva L
Acta Dermatovenerol Croat; 2019 Jun; 27(2):124-126. PubMed ID: 31351509
[TBL] [Abstract][Full Text] [Related]
26. Subacute cutaneous lupus erythematosus associated with radioiodine treatment.
Abbott RA; May K; Motley RJ
Clin Exp Dermatol; 2012 Oct; 37(7):753-4. PubMed ID: 22369225
[TBL] [Abstract][Full Text] [Related]
27. Are there distinct clinical and pathological features distinguishing idiopathic from drug-induced subacute cutaneous lupus erythematosus? A European retrospective multicenter study.
Guicciardi F; Atzori L; Marzano AV; Tavecchio S; Girolomoni G; Colato C; Villani AP; Kanitakis J; Mitteldorf C; Satta R; Cribier B; Gusdorf L; Rossi MT; Calzavara-Pinton P; Bielsa I; Fernandez-Figueras MT; Kempf W; Filosa G; Pilloni L; Rongioletti F
J Am Acad Dermatol; 2019 Aug; 81(2):403-411. PubMed ID: 30763648
[TBL] [Abstract][Full Text] [Related]
28. Subacute cutaneous lupus erythematosus: 25-year evolution of a prototypic subset (subphenotype) of lupus erythematosus defined by characteristic cutaneous, pathological, immunological, and genetic findings.
Sontheimer RD
Autoimmun Rev; 2005 Jun; 4(5):253-63. PubMed ID: 15990071
[TBL] [Abstract][Full Text] [Related]
29. Deposition of membrane attack complex in cutaneous lesions of lupus erythematosus.
Helm KF; Peters MS
J Am Acad Dermatol; 1993 May; 28(5 Pt 1):687-91. PubMed ID: 7684407
[TBL] [Abstract][Full Text] [Related]
30. Matrix metalloproteinases as mediators of tissue injury in different forms of cutaneous lupus erythematosus.
Järvinen TM; Kanninen P; Jeskanen L; Koskenmies S; Panelius J; Hasan T; Ranki A; Saarialho-Kere U
Br J Dermatol; 2007 Nov; 157(5):970-80. PubMed ID: 17854363
[TBL] [Abstract][Full Text] [Related]
31. Comparative analysis of subacute cutaneous lupus erythematosus and chronic cutaneous lupus erythematosus: clinical and immunological study of 270 patients.
Vera-Recabarren MA; García-Carrasco M; Ramos-Casals M; Herrero C
Br J Dermatol; 2010 Jan; 162(1):91-101. PubMed ID: 19785596
[TBL] [Abstract][Full Text] [Related]
32. Terbinafine-induced subacute cutaneous lupus erythematosus.
Farhi D; Viguier M; Cosnes A; Reygagne P; Dubertret L; Revuz J; Roujeau JC; Bachelez H
Dermatology; 2006; 212(1):59-65. PubMed ID: 16319476
[TBL] [Abstract][Full Text] [Related]
33. UVB-induced leucocyte trafficking in the epidermis of photosensitive lupus erythematosus patients: normal depletion of Langerhans cells.
Janssens AS; Lashley EE; Out-Luiting CJ; Willemze R; Pavel S; de Gruijl FR
Exp Dermatol; 2005 Feb; 14(2):138-42. PubMed ID: 15679584
[TBL] [Abstract][Full Text] [Related]
34. Terbinafine-induced subacute cutaneous lupus erythematosus.
Hivnor CM; Hudkins ML; Bonner B
Cutis; 2008 Feb; 81(2):156-7. PubMed ID: 18441768
[TBL] [Abstract][Full Text] [Related]
35. Subacute cutaneous lupus erythematosus induced by chemotherapy: gemcitabine as a causative agent.
Wiznia LE; Subtil A; Choi JN
JAMA Dermatol; 2013 Sep; 149(9):1071-5. PubMed ID: 23842655
[TBL] [Abstract][Full Text] [Related]
36. Drug-induced subacute cutaneous lupus erythematosus associated with abatacept.
Figueredo Zamora E; Callen JP; Schadt CR
Lupus; 2021 Apr; 30(4):661-663. PubMed ID: 33349110
[TBL] [Abstract][Full Text] [Related]
37. Tissue eosinophilia: not an indicator of drug-induced subacute cutaneous lupus erythematosus.
Hillesheim PB; Bahrami S; Jeffy BG; Callen JP
Arch Dermatol; 2012 Feb; 148(2):190-3. PubMed ID: 22004879
[TBL] [Abstract][Full Text] [Related]
38. Lichenoid and subacute cutaneous lupus erythematosus-like dermatitis associated with antihistamine therapy.
Crowson AN; Magro CM
J Cutan Pathol; 1999 Feb; 26(2):95-9. PubMed ID: 10082400
[TBL] [Abstract][Full Text] [Related]
39. Subacute cutaneous lupus erythematosus and its association with drugs: a population-based matched case-control study of 234 patients in Sweden.
Grönhagen CM; Fored CM; Linder M; Granath F; Nyberg F
Br J Dermatol; 2012 Aug; 167(2):296-305. PubMed ID: 22458771
[TBL] [Abstract][Full Text] [Related]
40. IL-17 in cutaneous lupus erythematosus.
Tanasescu C; Balanescu E; Balanescu P; Olteanu R; Badea C; Grancea C; Vagu C; Bleotu C; Ardeleanu C; Georgescu A
Eur J Intern Med; 2010 Jun; 21(3):202-7. PubMed ID: 20493423
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
